Predictor Value of PD-L1 for Radiotherapy Response in Locally Advanced Non-Small Cell Lung Cancer


Creative Commons License

Demircan V., Acar E., Senturk E., Guzel C., Eroglu Arkoc N., AKYÜREK N., ...More

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.37, pp.227-238, 2022 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 37
  • Publication Date: 2022
  • Doi Number: 10.5505/tjo.2022.3523
  • Journal Name: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE
  • Page Numbers: pp.227-238
  • Keywords: NSCLC, PD-L1, RT, PHASE-III, RTOG 0617, CONCURRENT, CHEMORADIATION, PACLITAXEL, RESISTANCE, CISPLATIN, RADIATION, CETUXIMAB, SURVIVAL
  • Istanbul University Affiliated: No

Abstract

OBJECTIVE